DMD is a genetic disorder causing muscle degeneration and weakness, caused by an absence of the protein dystrophin. DMD usually affects only boys, with around 100 being born with the condition in the ...

Researchers at the University of Houston are pushing the boundaries of biomedical innovation with a discovery that could transform treatment for one of cancer’s most devastating complications. In a ...

Patients with rheumatoid arthritis increased their leg muscle volume when treated with an anti-rheumatic drug, offering new hope for improved muscle health. Publishing in the prestigious journal, The ...

Patients with rheumatoid arthritis who took tofacitinib for 6 months had increased lower limb and thigh muscle volume, a small prospective study found. “Tofacitinib is associated with an increase in ...

With the intensification of global population aging, muscle atrophy, characterized by the loss of muscle mass and function, has become an important health issue affecting the elderly. Researchers have ...

A protein called B cell lymphoma 6 (BCL6) could be key to maintaining healthy muscle mass, and potentially could be used to combat muscle wasting conditions in humans, a study in mice suggests.

Loss of muscle mass, also called muscle wasting or atrophy, can happen gradually as part of getting older or more suddenly due to underlying medical conditions. Other factors can contribute, like ...

WILMINGTON, Del., Oct. 30, 2023 /PRNewswire/ -- The muscle wasting disorders market generated revenues worth US$ 12.7 billion in 2022. The market is predicted to reach US$ 45.4 billion in 2031.

A dysfunction in muscle blood vessels could be to blame for the weak muscles and weight loss that most cancer patients experience, according to a new study from University of Illinois Chicago ...

Northstrive Biosciences Inc., a subsidiary of PMGC Holdings Inc., has announced the completion of a Phase I research project for its innovative oral probiotic, EL-22, designed to combat muscle-wasting ...